LPAR1 and idiopathic pulmonary fibrosis: Several LPAR1 antagonists (e.g., AM966, BMS-986020, SAR100842) have been tested in clinical trials as treatment of non-oncological diseases, such as IPF, with encouraging results [194,195,196].